THE VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL FOR CROHN'S DISEASE EFFECTIVELY PREDICTS CLINICAL REMISSION AT 54 WEEKS IN A "REAL WORLD" SETTING

Konstantina Chalakatevaki  1     Georgios Kokkotis  1     Evgenia Papathanasiou  2     Nikolaos Kioulos  1     Michalis Gizis  1     Matina Lydia Chatzinikolaou  1     Ioannis Koutsounas  1     Spyridon Michopoulos  2     Evanthia Zampeli  2     Giorgos Bamias  1    
1 3rd Department of Internal Medicine "Sotiria" Hospital, National and Kapodistrian University of Athens, Athens, Greece
2 Alexandra Hospital, Athens, Greece

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing